NASDAQ : AHCO
AdaptHealth Corp. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.81 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 775.11M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 775.11M |
| Enterprise Value | 2.80B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 133.41M |
| Shares Outstanding | 133.41M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 8.42% |
| Owned by Institutions (%) | 73.84% |
| Float | 85.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.23 |
| Forward PS | 0.26 |
| PB Ratio | 0.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.94 |
| P/OCF Ratio | 1.33 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.83 |
| EV / EBITDA | 4.79 |
| EV / EBIT | 17.65 |
| EV / FCF | 28.63 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.12 |
| Quick Ratio | 0.64 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 3.14 |
| Debt / FCF | 21.14 |
| Interest Coverage | 1.56 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -15.22% |
| Return on Assets (ROA) | 2.28% |
| Return on Invested Capital (ROIC) | 4.61% |
| Return on Capital Employed (ROCE) | 4.36% |
| Weighted Average Cost of Capital (WACC) | 6.11% |
| Revenue Per Employee | $308,568 |
| Profits Per Employee | -$20,881 |
| Employee Count | 10,900 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 21.38 |
Taxes
| Measure | Value |
|---|
| Income Tax | -7.80M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -36.64% |
| 50-Day Moving Average | 5.88 |
| 200-Day Moving Average | 9.19 |
| Relative Strength Index (RSI) | 44.23 |
| Average Volume (20 Days) | 2,176,078 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 10.24M |
| Short Previous Month | 9.59M |
| Short % of Shares Out | 7.67% |
| Short % of Float | 11.93% |
| Short Ratio (days to cover) | 3.48 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.36B |
| Gross Profit | 644.93M |
| Operating Income | 158.50M |
| Pretax Income | -234.68M |
| Net Income | -227.60M |
| EBITDA | 583.47M |
| EBIT | 158.50M |
| Loss Per Share | -$1.68 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 43.29M |
| Total Debt | 2.07B |
| Net Cash | -2.02B |
| Net Cash Per Share | -$15.15 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 10.34 |
| Working Capital | 88.26M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 583.27M |
| Capital Expenditures | -485.59M |
| Depreciation & Amortization | 424.97M |
| Net Borrowing | 56.75M |
| Free Cash Flow | 97.68M |
| FCF Per Share | $0.73 |
Margins
| Measure | Value |
|---|
| Gross Margin | 19.18% |
| Operating Margin | 4.71% |
| Pretax Margin | -6.98% |
| Profit Margin | -6.79% |
| EBITDA Margin | 17.35% |
| EBIT Margin | 4.71% |
| FCF Margin | 2.90% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -28.87% |
| FCF Yield | 12.60% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.86 |
| Price Target Difference | 52.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -1.19% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.94 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |